StockData
Treace Medical Concepts, Inc. logo

Treace Medical Concepts, Inc. (TMCI) stock

TMCINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3031% below fair value
$4.44+0.02 (+0.45%)

Close on Nov 17, 2026Market cap $288.75MP/E –Yield –

Treace Medical Concepts total assets

Total assets on the balance sheet at the end of each period.

Treace Medical Concepts's total assets was $181.06M at Jun 30, 2026. For fiscal 2025 it was $190.58M, down 12.2% from the year before. The highest annual figure on record is $251.91M in fiscal 2023.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$190.58M-12.2%
FY2024Dec 31, 2024$217.09M-13.8%
FY2023Dec 31, 2023$251.91M+58.4%
FY2022Dec 31, 2022$159.02M+12.9%
FY2021Dec 31, 2021$140.82M+236.8%
FY2020Dec 31, 2020$41.81M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$181.06M-12.3%
Q1 FY2026Mar 31, 2026$184.10M-10.6%
Q4 FY2025Dec 31, 2025$190.58M-12.2%
Q3 FY2025Sep 30, 2025$196.59M-7.7%
Q2 FY2025Jun 30, 2025$206.44M-8.7%
Q1 FY2025Mar 31, 2025$205.85M-15.2%
Q4 FY2024Dec 31, 2024$217.09M-13.8%
Q3 FY2024Sep 30, 2024$212.92M-11.4%
Q2 FY2024Jun 30, 2024$226.08M-9.4%
Q1 FY2024Mar 31, 2024$242.73M-2.6%
Q4 FY2023Dec 31, 2023$251.91M+58.4%
Q3 FY2023Sep 30, 2023$240.36M+53.6%
Q2 FY2023Jun 30, 2023$249.64M+57.3%
Q1 FY2023Mar 31, 2023$249.17M+70.1%
Q4 FY2022Dec 31, 2022$159.02M+12.9%
Q3 FY2022Sep 30, 2022$156.44M+13.7%
Q2 FY2022Jun 30, 2022$158.72M+11.5%
Q1 FY2022Mar 31, 2022$146.51M+291.9%
Q4 FY2021Dec 31, 2021$140.82M+236.8%
Q3 FY2021Sep 30, 2021$137.59M–
Q2 FY2021Jun 30, 2021$142.30M–
Q1 FY2021Mar 31, 2021$37.38M–
Q4 FY2020Dec 31, 2020$41.81M–

More Treace Medical Concepts figures

See a number that looks wrong?